Clinical Trials: Impact & Quality
CT:IQ aims to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia.
This project will engage the clinical trial industry in Australia to determine the actions needed to strengthen Australia as an attractive clinical trial research destination. The project will determine at least two activities in year one and three in year two as a focus to achieve an improved national clinical trial sector.
Outcomes: Five sector-wide, industry-led projects are complete, including clinical trial design and electronic consent. The CT:IQ membership now represents over 100 individuals from over 65 companies. Through the project CT:IQ has delivered 36 events to over 3900 people.
| State | South Australia |
| Consortium Lead | Bellberry Limited |
| Consortium Members | ACTA, NHMRC CTC and The George Institute with an additional 25 organisations representing the diverse clinical trials sector. |
| MTPConnect Grant | $370,000 |
| Industry Contribution | $850,455 |
| Other Government Contribution | $3,000 |
| Project Duration | January 2018 – March 2021 |
| Contact | Leanne Weekes, CT:IQ - LeanneWeekes@ctiq.com.au |
Visit CT:IQ for more information | Twitter: @CTImpactQuality | LinkedIn: CT:IQ